Functional cardiac tissue engineering.

Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23

Engineered electrical conduction tract restores conduction in complete heart block: from in vitro to in vivo proof of concept. J Am Coll Cardiol (2014) 1.43

Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One (2013) 1.00

Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication (2014) 0.98

Cell-laden microengineered and mechanically tunable hybrid hydrogels of gelatin and graphene oxide. Adv Mater (2013) 0.97

Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies. Adv Drug Deliv Rev (2015) 0.91

Biomaterial based cardiac tissue engineering and its applications. Biomed Mater (2015) 0.88

Three-dimensional elastomeric scaffolds designed with cardiac-mimetic structural and mechanical features. Tissue Eng Part A (2012) 0.86

Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function. Circ Arrhythm Electrophysiol (2016) 0.84

Layer-by-layer assembly of 3D tissue constructs with functionalized graphene. Adv Funct Mater (2014) 0.84

Biomaterials in myocardial tissue engineering. J Tissue Eng Regen Med (2014) 0.84

Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev (2015) 0.83

Aligned carbon nanotube-based flexible gel substrates for engineering bio-hybrid tissue actuators. Adv Funct Mater (2015) 0.83

Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials (2016) 0.81

Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells. Cytotechnology (2014) 0.80

PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium. Cell Death Dis (2014) 0.77

Pluripotent stem cells as a platform for cardiac arrhythmia drug screening. Curr Treat Options Cardiovasc Med (2014) 0.76

Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue. Biomaterials (2017) 0.75

Graphene-based materials for tissue engineering. Adv Drug Deliv Rev (2016) 0.75

Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs. Sci Rep (2016) 0.75

Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids. Acta Biomater (2017) 0.75

A conducting polymer with enhanced electronic stability applied in cardiac models. Sci Adv (2016) 0.75

Naturally Engineered Maturation of Cardiomyocytes. Front Cell Dev Biol (2017) 0.75

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51

Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42

Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93

Tissue engineering. Science (1993) 19.65

Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09

Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18

Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature (1976) 13.78

BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 13.47

Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38

Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell (2008) 10.34

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 10.27

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35

Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell (2003) 8.00

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell (2006) 7.21

Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09

Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A (2002) 6.98

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71

Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19

Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 5.68

Regenerating the heart. Nat Biotechnol (2005) 5.58

Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res (2003) 5.12

Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74

Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68

STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55

Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng (2006) 4.53

Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50

Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science (1994) 4.41

An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35

Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods (2009) 4.27

Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell (2009) 4.21

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13

Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00

Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98

Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87

IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature (2007) 3.74

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol (2001) 3.66

Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res (2002) 3.52

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature (2007) 3.46

A genetic blueprint for cardiac development. Nature (2000) 3.45

Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science (2001) 3.44

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30

Differences between human and mouse embryonic stem cells. Dev Biol (2004) 3.30

Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25

Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol (2011) 3.21

Optical imaging of the heart. Circ Res (2004) 3.14

Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97

SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol (2011) 2.84

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res (1994) 2.82

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res (2007) 2.74

Myoblast transplantation for heart failure. Lancet (2001) 2.71

Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64

Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60

Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells (2007) 2.58

Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A (2009) 2.51

Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther (2007) 2.50

Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res (2004) 2.38

NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods (2011) 2.29

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells (2007) 2.28

Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation (2006) 2.26

Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26

Cell-based cardiac repair: reflections at the 10-year point. Circulation (2005) 2.25

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23

Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21

Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation (1994) 2.21

Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development (2008) 2.14

Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J (2007) 2.10

Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells (2007) 2.10

Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09

Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res (2004) 2.09

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest (2010) 2.06

Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells (2005) 2.06

Development of a drug screening platform based on engineered heart tissue. Circ Res (2010) 2.04

Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One (2008) 1.99

Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ Res (2003) 1.95

High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res (2002) 1.91

Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc Natl Acad Sci U S A (2009) 1.89

Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ Res (2001) 1.83

Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest (1997) 1.83

Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest (2008) 1.80

Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells (2008) 1.75

Engineering myocardial tissue. Circ Res (2005) 1.75

Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74

Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture. J Physiol (1994) 1.71

Establishment of cardiac cytoarchitecture in the developing mouse heart. Dev Biol (2005) 1.68

Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res (2010) 1.67

Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc Res (2011) 1.67

Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res (2003) 1.66

Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg (2003) 1.66

Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol (2004) 1.65

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials (2013) 1.97

The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials (2011) 1.68

Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One (2013) 1.52

Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc (2009) 1.45

Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res (2009) 1.40

Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts. Circ Res (2011) 1.37

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem (2002) 1.31

Novel micropatterned cardiac cell cultures with realistic ventricular microstructure. Biophys J (2009) 1.30

Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials (2011) 1.30

Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol (2008) 1.28

Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials (2008) 1.28

Molecular ecology of pyrethroid knockdown resistance in Culex pipiens pallens mosquitoes. PLoS One (2010) 1.27

Theory of femtosecond stimulated Raman spectroscopy. J Chem Phys (2004) 1.27

Functional reentry in cultured monolayers of neonatal rat cardiac cells. Am J Physiol Heart Circ Physiol (2003) 1.22

Formation of tellurium nanocrystals during anaerobic growth of bacteria that use Te oxyanions as respiratory electron acceptors. Appl Environ Microbiol (2007) 1.18

Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. Nat Commun (2011) 1.10

Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci U S A (2014) 1.10

Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. Am J Physiol Cell Physiol (2009) 1.09

Primordial germ cell specification from embryonic stem cells. PLoS One (2008) 1.09

Whole-cell-analysis of live cardiomyocytes using wide-field interferometric phase microscopy. Biomed Opt Express (2010) 1.08

Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. J Mol Cell Cardiol (2006) 1.08

Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers. Cell Mol Bioeng (2008) 1.04

The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro. J Neuroimmunol (2013) 1.03

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo. Virology (2003) 1.03

Local tissue geometry determines contractile force generation of engineered muscle networks. Tissue Eng Part A (2012) 1.03

Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun (2003) 1.02

Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells. IEEE Eng Med Biol Mag (2008) 1.01

Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One (2010) 1.01

Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One (2013) 1.00

Mechanoelectrical excitation by fluid jets in monolayers of cultured cardiac myocytes. J Appl Physiol (1985) (2005) 1.00

Cardiac tissue engineering using stem cells. IEEE Eng Med Biol Mag (2009) 0.97

Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One (2010) 0.96

Genome sequence of Anopheles sinensis provides insight into genetics basis of mosquito competence for malaria parasites. BMC Genomics (2014) 0.95

CD24: a novel surface marker for PDX1-positive pancreatic progenitors derived from human embryonic stem cells. Stem Cells (2011) 0.95

Graphene-supported ultrafine metal nanoparticles encapsulated by mesoporous silica: robust catalysts for oxidation and reduction reactions. Angew Chem Int Ed Engl (2013) 0.95

Live offspring produced by mouse oocytes derived from premeiotic fetal germ cells. Biol Reprod (2006) 0.94

Soluble miniagrin enhances contractile function of engineered skeletal muscle. FASEB J (2011) 0.93

A method to replicate the microstructure of heart tissue in vitro using DTMRI-based cell micropatterning. Ann Biomed Eng (2009) 0.93

WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs. Stem Cell Reports (2013) 0.93

Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng Med Biol Mag (2008) 0.90

Functionalization of carbon nanotubes with bovine serum albumin in homogeneous aqueous solution. J Nanosci Nanotechnol (2002) 0.89

Expression and characterization of two pesticide resistance-associated serine protease genes (NYD-tr and NYD-ch) from Culex pipiens pallens for metabolism of deltamethrin. Parasitol Res (2008) 0.89

Cyclic poly(alpha-peptoid)s and their block copolymers from N-heterocyclic carbene-mediated ring-opening polymerizations of N-substituted N-carboxylanhydrides. J Am Chem Soc (2009) 0.89

Engineering skeletal muscle repair. Curr Opin Biotechnol (2013) 0.88

Multiple vaccinations with UV- attenuated cercariae in pig enhance protective immunity against Schistosoma japonicum infection as compared to single vaccination. Parasit Vectors (2011) 0.88

Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines. Oncogene (2002) 0.88

Issues for improving multiplasmid DNA vaccines for HIV-1. Vaccine (2002) 0.87

Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs. Circ Arrhythm Electrophysiol (2012) 0.87

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. Am J Vet Res (2004) 0.87

Robust methods for population stratification in genome wide association studies. BMC Bioinformatics (2013) 0.87

Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. Am J Physiol Heart Circ Physiol (2006) 0.87

Design considerations for an integrated microphysiological muscle tissue for drug and tissue toxicity testing. Stem Cell Res Ther (2013) 0.86

Reflective interferometric chamber for quantitative phase imaging of biological sample dynamics. J Biomed Opt (2010) 0.85

Conduction block in micropatterned cardiomyocyte cultures replicating the structure of ventricular cross-sections. Cardiovasc Res (2011) 0.85

Single-detector simultaneous optical mapping of V(m) and [Ca(2+)](i) in cardiac monolayers. Ann Biomed Eng (2011) 0.84

MiR-278-3p regulates pyrethroid resistance in Culex pipiens pallens. Parasitol Res (2014) 0.84

Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe disease. FASEB J (2014) 0.84

Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis. Front Neurol (2013) 0.83

General route toward side-chain-functionalized alpha-helical polypeptides. Biomacromolecules (2010) 0.83

A method to measure myocardial calcium handling in adult Drosophila. Circ Res (2011) 0.83

Genetic engineering of somatic cells to study and improve cardiac function. Europace (2012) 0.83

Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles. Ann Biomed Eng (2013) 0.83

HIV-1 viral protein R compromises cellular immune function in vivo. Int Immunol (2002) 0.83

Naturally occurring incompatibilities between different Culex pipiens pallens populations as the basis of potential mosquito control measures. PLoS Negl Trop Dis (2013) 0.82

Mature oocytes derived from purified mouse fetal germ cells. Hum Reprod (2007) 0.82

IFN-inducible p47 GTPases display differential responses to Schistosoma japonicum acute infection. Cell Mol Immunol (2009) 0.82

Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the dark agouti rat model of experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther (2013) 0.81

Cloning and characterization of ribosomal protein S29, a deltamethrin resistance associated gene from Culex pipiens pallens. Parasitol Res (2011) 0.81

Upregulated expression of cytotoxicity-related genes in IFN-γ knockout mice with Schistosoma japonicum infection. J Biomed Biotechnol (2011) 0.81

Cloning and overexpression of ribosomal protein L39 gene from deltamethrin-resistant Culex pipiens pallens. Exp Parasitol (2006) 0.81

A computer model of engineered cardiac monolayers. Biophys J (2010) 0.81

A comparison of bias-corrected covariance estimators for generalized estimating equations. J Biopharm Stat (2013) 0.81

Cloning and characterization of 60S ribosomal protein L22 (RPL22) from Culex pipiens pallens. Comp Biochem Physiol B Biochem Mol Biol (2009) 0.81

On sample size of the kruskal-wallis test with application to a mouse peritoneal cavity study. Biometrics (2011) 0.81

Dependence of line shapes in femtosecond broadband stimulated Raman spectroscopy on pump-probe time delay. J Chem Phys (2005) 0.80

Cardiac fibroblasts in pressure overload hypertrophy: the enemy within? J Clin Invest (2014) 0.80

Synthesis and characterization of cyclic and linear helical poly(alpha-peptoids)s by N-heterocyclic carbene-mediated ring-opening polymerizations of N-substituted N-carboxyanhydrides. Biopolymers (2011) 0.80

Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineage. PLoS One (2012) 0.80

Partial characterization of deltamethrin metabolism catalyzed by chymotrypsin. Toxicol In Vitro (2008) 0.80

Glycogen branching enzyme: a novel deltamethrin resistance-associated gene from Culex pipiens pallens. Parasitol Res (2008) 0.80

Cloning and characterization of myosin regulatory light chain (MRLC) gene from Culex pipiens pallens. Comp Biochem Physiol B Biochem Mol Biol (2008) 0.80

CLU rs2279590 polymorphism contributes to Alzheimer's disease susceptibility in Caucasian and Asian populations. J Neural Transm (Vienna) (2014) 0.79

X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector. Hum Gene Ther (2012) 0.79

Identification of proteasome subunit beta type 6 (PSMB6) associated with deltamethrin resistance in mosquitoes by proteomic and bioassay analyses. PLoS One (2013) 0.79

Cloning and characterization of prophenoloxidase A3 (proPOA3) from Culex pipiens pallens. Comp Biochem Physiol B Biochem Mol Biol (2012) 0.79

A review of dynamical resonances in A  +  BC chemical reactions. Rep Prog Phys (2016) 0.78

Synthesis and Characterization of Amphiphilic Cyclic Diblock Copolypeptoids from N-Heterocyclic Carbene-Mediated Zwitterionic Polymerization of N-Substituted N-carboxyanhydride. Macromolecules (2011) 0.78

Quantifying electrical interactions between cardiomyocytes and other cells in micropatterned cell pairs. Methods Mol Biol (2014) 0.78

Genetic engineering and stem cells: combinatorial approaches for cardiac cell therapy. IEEE Eng Med Biol Mag (2008) 0.78

Cloning and characterization of 40S ribosomal protein S4 gene from Culex pipiens pallens. Comp Biochem Physiol B Biochem Mol Biol (2006) 0.78

N-Heterocyclic carbene-mediated zwitterionic polymerization of N-substituted N-carboxyanhydrides toward poly(α-peptoid)s: kinetic, mechanism, and architectural control. J Am Chem Soc (2012) 0.77

Spatial profiles of electrical mismatch determine vulnerability to conduction failure across a host-donor cell interface. Circ Arrhythm Electrophysiol (2013) 0.77

Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation. Mol Med Rep (2013) 0.77

Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Cancer Lett (2012) 0.76

A note on power and sample size calculations for the Kruskal-Wallis test for ordered categorical data. J Biopharm Stat (2012) 0.76

Collision-based spiral acceleration in cardiac media: roles of wavefront curvature and excitable gap. Biophys J (2010) 0.76

Mouse oocytes derived from fetal germ cells are competent to support the development of embryos by in vitro fertilization. Mol Reprod Dev (2006) 0.76

Ribose-phosphate pyrophosphokinase 1 (PRPS1) associated with deltamethrin resistance in Culex pipiens pallens. Parasitol Res (2012) 0.75

Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Circ J (2016) 0.75